These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 7608619

  • 21. Analysis of FIGO Stage IIIc endometrial cancer patients.
    McMeekin DS, Lashbrook D, Gold M, Johnson G, Walker JL, Mannel R.
    Gynecol Oncol; 2001 May; 81(2):273-8. PubMed ID: 11330962
    [Abstract] [Full Text] [Related]

  • 22. Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma.
    Sakuragi N, Hareyama H, Todo Y, Yamada H, Yamamoto R, Fujino T, Sagawa T, Fujimoto S.
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):311-6. PubMed ID: 10746848
    [Abstract] [Full Text] [Related]

  • 23. [Multivariate analysis of prognostic factors in endometrial carcinoma].
    Li B, Wu LY, Li SM, Zhang WH, Zhang R, Ma SK.
    Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
    [Abstract] [Full Text] [Related]

  • 24. Prognostic significance of malignant cervical cytology in patients with endometrial cancer.
    Larson DM, Johnson KK, Reyes CN, Broste SK.
    Obstet Gynecol; 1994 Sep; 84(3):399-403. PubMed ID: 8058238
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of preoperative criteria used to predict lymph node metastasis in endometrial cancer.
    Han SS, Lee SH, Kim DH, Kim JW, Park NH, Kang SB, Song YS.
    Acta Obstet Gynecol Scand; 2010 Sep; 89(2):168-74. PubMed ID: 19916890
    [Abstract] [Full Text] [Related]

  • 26. [The comparison of clinical and surgical-pathological staging for endometrial carcinoma].
    Peng Z, Liu X, Zhang J.
    Zhonghua Fu Chan Ke Za Zhi; 1997 Oct; 32(10):597-600. PubMed ID: 9642375
    [Abstract] [Full Text] [Related]

  • 27. High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy.
    Sonoda Y, Zerbe M, Smith A, Lin O, Barakat RR, Hoskins WJ.
    Gynecol Oncol; 2001 Mar; 80(3):378-82. PubMed ID: 11263935
    [Abstract] [Full Text] [Related]

  • 28. Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinoma.
    Takeshima N, Shimizu Y, Umezawa S, Hirai Y, Chen JT, Fujimoto I, Yamauchi K, Hasumi K.
    Gynecol Oncol; 1994 Sep; 54(3):321-6. PubMed ID: 8088608
    [Abstract] [Full Text] [Related]

  • 29. [A risk score for operated endometrial cancer and its importance for adjuvant radiotherapy (histopathology and results of treatment based on 208 cases with pelvic lymph node excision)].
    Kucera H, Vavra N.
    Geburtshilfe Frauenheilkd; 1991 Oct; 51(10):798-805. PubMed ID: 1761168
    [Abstract] [Full Text] [Related]

  • 30. Predicting pelvic lymph node metastasis in endometrial carcinoma.
    Kamura T, Yahata H, Shigematsu T, Ogawa S, Amada S, Kaku T, Nakano H.
    Gynecol Oncol; 1999 Mar; 72(3):387-91. PubMed ID: 10053111
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of parametrial spread in endometrial carcinoma.
    Watanabe Y, Satou T, Nakai H, Etoh T, Dote K, Fujinami N, Hoshiai H.
    Obstet Gynecol; 2010 Nov; 116(5):1027-34. PubMed ID: 20966685
    [Abstract] [Full Text] [Related]

  • 32. Percent surface area involvement is a predictor of lymph node metastasis in endometrial cancer.
    Axtell AE, Kelley JL, Fader AN, Gupta D, Schwartz B, Comerci JT, Lin Y, Weiand S, Gallion HH, Kanbour-Shakir A.
    Gynecol Oncol; 2007 Dec; 107(3):482-6. PubMed ID: 17850853
    [Abstract] [Full Text] [Related]

  • 33. Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma.
    Mohan DS, Samuels MA, Selim MA, Shalodi AD, Ellis RJ, Samuels JR, Yun HJ.
    Gynecol Oncol; 1998 Aug; 70(2):165-71. PubMed ID: 9740684
    [Abstract] [Full Text] [Related]

  • 34. Correlation between pretreatment prognostic factors and lymph node metastases in endometrial adenocarcinoma. Clinical application.
    La Fianza A, Alberici E, Generoso P, Preda L, Campani R.
    Radiol Med; 2000 Nov; 100(5):363-6. PubMed ID: 11213416
    [Abstract] [Full Text] [Related]

  • 35. Predictors of final histology in patients with endometrial cancer.
    Frumovitz M, Singh DK, Meyer L, Smith DH, Wertheim I, Resnik E, Bodurka DC.
    Gynecol Oncol; 2004 Dec; 95(3):463-8. PubMed ID: 15581947
    [Abstract] [Full Text] [Related]

  • 36. Intraoperative evaluation of depth of myometrial invasion in stage I endometrial adenocarcinoma.
    Doering DL, Barnhill DR, Weiser EB, Burke TW, Woodward JE, Park RC.
    Obstet Gynecol; 1989 Dec; 74(6):930-3. PubMed ID: 2586959
    [Abstract] [Full Text] [Related]

  • 37. Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma.
    Schwab KV, O'Malley DM, Fowler JM, Copeland LJ, Cohn DE.
    Gynecol Oncol; 2009 Jan; 112(1):146-9. PubMed ID: 18937970
    [Abstract] [Full Text] [Related]

  • 38. Use of the sentinel node procedure to stage endometrial cancer.
    Ballester M, Dubernard G, Rouzier R, Barranger E, Darai E.
    Ann Surg Oncol; 2008 May; 15(5):1523-9. PubMed ID: 18322758
    [Abstract] [Full Text] [Related]

  • 39. Relationship of nonstaging pathological risk factors to lymph node metastasis and recurrence in clinical stage I endometrial carcinoma.
    Bell JG, Minnick A, Reid GC, Judis J, Brownell M.
    Gynecol Oncol; 1997 Sep; 66(3):388-92. PubMed ID: 9299250
    [Abstract] [Full Text] [Related]

  • 40. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?
    Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC.
    Am J Obstet Gynecol; 2000 Jun; 182(6):1506-19. PubMed ID: 10871473
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.